Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Publication/Presentation Date
1-1-2020
Volume
10
First Page
576924
Last Page
576924
ISSN
2234-943X
Published In/Presented At
Pan, J., Altman, D., & Wilde, L. (2020). Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Frontiers in oncology, 10, 576924. https://doi.org/10.3389/fonc.2020.576924
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
33194691
Department(s)
Administration and Leadership
Document Type
Article
COinS